Drug Guide
Quinethazone and Reserpine
Classification
Therapeutic: Antihypertensive, Diuretic (Quinethazone), Antipsychotic (Reserpine)
Pharmacological: Diuretic (Quinethazone), Adrenergic Neuron Blocker (Reserpine)
FDA Approved Indications
- Hypertension (Reserpine)
- Edema (Quinethazone)
Mechanism of Action
Quinethazone inhibits sodium and chloride reabsorption in the distal tubules of the kidney, promoting diuresis. Reserpine irreversibly blocks the storage of neurotransmitters (dopamine, norepinephrine, serotonin) in sympathetic nerve endings, reducing sympathetic activity and lowering blood pressure.
Dosage and Administration
Adult: Dose varies; typically, Reserpine 0.1-0.5 mg once daily, titrated as needed. Quinethazone dosage depends on indication and response.
Pediatric: Not generally recommended for children.
Geriatric: Use cautiously; start at lower doses due to increased sensitivity.
Renal Impairment: Adjust dose based on renal function.
Hepatic Impairment: Use with caution; no specific dosage adjustment information.
Pharmacokinetics
Absorption: Orally absorbed.
Distribution: Widely distributed throughout the body.
Metabolism: Primarily hepatic metabolism.
Excretion: Renal excretion; metabolites and unchanged drug.
Half Life: Reserpine: approximately 24 hours.
Contraindications
- Depressive states, peptic ulcer, asthma, head trauma.
- Known hypersensitivity to the components.
Precautions
- Use with caution in patients with Parkinson's disease, depression, or peptic ulcer disease. Monitor blood pressure closely. Risk of depression with Reserpine.
Adverse Reactions - Common
- Sedation, nasal congestion, gastrointestinal upset (Common)
Adverse Reactions - Serious
- Depression, bradycardia, peptic ulcer exacerbation, nasal congestion leading to potential airway compromise (Serious (less common))
Drug-Drug Interactions
- MAO inhibitors, centrally acting agents, tricyclic antidepressants, other antihypertensives
Drug-Food Interactions
N/ADrug-Herb Interactions
N/ANursing Implications
Assessment: Monitor blood pressure, heart rate, mental status, and signs of depression.
Diagnoses:
- Risk for hypotension, risk for depression, impaired gas exchange due to nasal congestion.
Implementation: Administer as prescribed; monitor vitals regularly; evaluate mental health status.
Evaluation: Assess blood pressure response, mental health status, and adverse effects.
Patient/Family Teaching
- Take medication exactly as prescribed.
- Report signs of depression or suicidal ideation.
- Caution about possible sedation and orthostatic hypotension.
- Avoid abrupt discontinuation.
Special Considerations
Black Box Warnings:
- Risk of depression and suicidal thoughts with Reserpine.
Genetic Factors: None specific.
Lab Test Interference: None noted.
Overdose Management
Signs/Symptoms: Severe hypotension, depression, rapid decrease in blood pressure.
Treatment: Supportive care, IV fluids, activated charcoal if ingestion is recent, monitor cardiovascular status.
Storage and Handling
Storage: Store at room temperature, away from moisture and light.
Stability: Stable under recommended storage conditions.